A

Researcher Profile

Anna Staniszewska

3

Publications

84

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Oncogene Oct 14, 2022

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors

Shanade Dunn · Cath Eberlein · Jason Yu · Albert Gris-Oliver +17 more

10.1038/s41388-022-02482-9 33 citations

Journal Article Blood Nov 04, 2021

Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity

Antonio Sacco · Cinzia Federico · Katia Todoerti · Bachisio Ziccheddu +30 more

10.1182/blood.2020010572 20 citations

Journal Article Clinical Cancer Research Dec 14, 2017

Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors

James T. Lynch · Urszula M. Polanska · Oona Delpuech · Urs Hancox +14 more

10.1158/1078-0432.ccr-17-0676 31 citations

Publication Timeline

2022

1

2021

1

2017

1

Frequent Co-Authors

Rossella Ribolla

Alessandra Tucci